Copyright
©The Author(s) 2021.
World J Psychiatr. Oct 19, 2021; 11(10): 736-753
Published online Oct 19, 2021. doi: 10.5498/wjp.v11.i10.736
Published online Oct 19, 2021. doi: 10.5498/wjp.v11.i10.736
Figure 1 Summary of clinical manifestations of antipsychotic cardiotoxicity.
Typical characteristics for each manifestation are concisely listed in black texts. SGA: Second-generation antipsychotic; FGA: First-generation antipsychotic; TdP: Torsades de pointes.
Figure 2 Summary of cardiac pathological changes in response to antipsychotic treatments.
Typical characteristics of each pathological change are concisely listed in black text. SGA: Second-generation antipsychotic; FGA: First-generation antipsychotic; ASCVD: Atherosclerotic cardiovascular disease; MI: Myocardial infarction.
- Citation: Li XQ, Tang XR, Li LL. Antipsychotics cardiotoxicity: What's known and what's next. World J Psychiatr 2021; 11(10): 736-753
- URL: https://www.wjgnet.com/2220-3206/full/v11/i10/736.htm
- DOI: https://dx.doi.org/10.5498/wjp.v11.i10.736